Plus therapeutics to present at the h.c. wainwright 26th annual global investment conference

Austin, texas, sept. 04, 2024 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (“plus” or the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (cns) cancers, today announced that marc h.
pstv Ratings Summary
pstv Quant Ranking